Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	DrugBank	Drug (Description in trials)	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Irbesartan	[12] Irbesartan; Irbesartan 150-300mg capsules daily for 6 months; Irbesartan approved in the netherlands; Irbesartan tablets; Irbesartan tablets (approved in the usa. reference listed drug avapro) ndc # 43547-0374-03; Irbesartan tablets (ndc# 0955-1041-90 approved in the usa); Irbesartan tablets (ndc# 43547-0374-03 and ndc 43547-374-09, approved in the usa) generic tablets distributed by solco healthcare us, llc; Irbesartan tablets (ndc# 43547-375-50 approved in the usa) generic tablets distributed by solco healthcare us, llc; Over-encapsulated 150 mg irbesartan tablets; Over-encapsulated 75 mg irbesartan tablets; Over-encapsulated irbesartan; Over-encapsulated irbesartan tablets;	[1] D00523 💬	[1] AGTR1 💬	[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway	[4] 66, 167, 168, 222 💬